• Keine Ergebnisse gefunden

1. Albani C, Blaser G, Geyer M, Schmutzer G, Hinz A, Bailer H, Grulke N, Brähler E (2006). Validierung und Normierung des “Fragebogen zur Erfassung des Körperlichen Wohlbefindens” (FEW-16) von Kolip und Schmidt an einer

repräsentativen deutschen Bevölkerungsstichprobe. Psychother Psychosom Med Psychol 56: 172–181.

2. Andreas S, Harfst T, Dirmaier J, Kawski S, Koch U, Schulz H (2007). A Psychometric evaluation of the German version of the “Health of the Nation Outcome Scales, HoNOS-D”: on the feasibility and reliability of clinician-performed measurements of severity in patients with mental disorders. Psychopathology 40: 116–125.

3. AOK (2019). https://www.aok.de/pk/bayern/inhalt/daten-und-fakten/

(05.08.2019).

4. Armstrong M J, Mottershead T A, Ronksley P E, Sigal R J, Campbell T S, Hemmelgarn B R (2011). Motivational interviewing to improve weight loss in overweight and/or obese patients: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 12: 709–723.

5. Austin P C (2011). An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behav Res 46: 399–

424.

6. Austin P C (2009). The relative ability of different propensity score methods to balance measured covariates between treated and untreated subjects in observational studies. Med Decis Making 29: 661–677.

7. Bak M, Fransen A, Janssen J, Os J van, Drukker M (2014). Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One 9: e94112.

8. Bartels S J, Pratt S I, Aschbrenner K A, Barre L K, Jue K, Wolfe R S, Xie H, McHugo G, Santos M, Williams G E (2013). Clinically significant improved fitness and weight loss among overweight persons with serious mental illness. Psychiatr Serv 64: 729–

736.

9. Bartels S J, Pratt S I, Aschbrenner K A, Barre L K, Naslund J A, Wolfe R, Xie H, McHugo G J, Jimenez D E, Jue K (2015). Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of

152 outcomes. Am J Psychiatry 172: 344–352.

10. Becker T, Kilian R (2008). European Network for Promoting the Health of Residents in Psychiatric and Social Care Institutions.

https://www.uni-ulm.de/helps-net/index.htm (20.05.2019).

11. Bizzarri J V, Rucci P, Sbrana A, Miniati M, Raimondi F, Ravani L, Massei G J, Milani F, Milianti M, Massei G, Gonnelli C, Cassano G B (2009). Substance use in severe mental illness: self-medication and vulnerability factors. Psychiatry Res 165: 88–95.

12. Blanner Kristiansen C, Juel A, Vinther Hansen M, Hansen A M, Kilian R, Hjorth P (2015). Promoting physical health in severe mental illness: patient and staff perspective. Acta Psychiatr Scand 132: 470–478.

13. Brandstätter H (1991). Alltagsereignisse und Wohlbefinden. S. 191–225. In:

Wohlbefinden. Theorie - Empirie - Diagnostik, (Abele A, Becker P Hrsg.) Juventa, Weinheim.

14. Britt E, Hudson S M, Blampied N M (2004). Motivational interviewing in health settings: a review. Patient Educ Couns 53: 147–155.

15. Brookhart M A, Schneeweiss S, Rothman K J, Glynn R J, Avorn J, Stürmer T (2006).

Variable selection for propensity score models. Am J Epidemiol 163: 1149–1156.

16. Brown S, Birtwistle J, Roe L, Thompson C (1999). The unhealthy lifestyle of people with schizophrenia. Psychol Med 29: 697–701.

17. Brown S, Inskip H, Barraclough B (2000). Causes of the excess mortality of schizophrenia. Br J Psychiatry 177: 212–217.

18. Burns T (2009). End of the road for treatment-as-usual studies? Br J Psychiatry 195:

5–6.

19. Carrà G, Johnson S, Crocamo C, Angermeyer M C, Brugha T, Azorin J-M, Toumi M, Bebbington P E (2016). Psychosocial functioning, quality of life and clinical

correlates of comorbid alcohol and drug dependence syndromes in people with schizophrenia across Europe. Psychiatry Res 239: 301–307.

20. Chacón F, Mora F, Gervás-Ríos A, Gilaberte I (2011). Efficacy of lifestyle interventions in physical health management of patients with severe mental illness. Ann Gen Psychiatry 10: 22.

21. Chanut F, Brown T G, Dongier M (2005). Motivational Interviewing and Clinical Psychiatry. Can J Psychiatry 50: 715–721.

153 22. Chesney E, Goodwin G M, Fazel S (2014). Risks of all-cause and suicide mortality in

mental disorders: a meta-review. World Psychiatry 13: 153–160.

23. Citters A D Van, Pratt S I, Jue K, Williams G, Miller P T, Xie H, Bartels S J (2010). A pilot evaluation of the In SHAPE individualized health promotion intervention for adults with mental illness. Community Ment Health J 46: 540–552.

24. Correll C U, Detraux J, Lepeleire J de, Hert M de (2015). Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry 14: 119–136.

25. Correll C U, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, Thapa-Chhetri N, Fornaro M, Gallicchio D, Collantoni E, Pigato G, Favaro A, Monaco F, Kohler C, Vancampfort D, Ward P B, Gaughran F, Carvalho A F, Stubbs B (2017).

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls. World Psychiatry 16: 163–180.

26. Creswell J W (2009). Mixed Methods Procedures. S. 203–224. In: Research Design:

Qualitative, Quantitative, and Mixed Methods Approaches, 3. Aufl., Sage Publications, Thousand Oaks.

27. Crump C, Sundquist K, Winkleby M A, Sundquist J (2013). Mental disorders and risk of accidental death. Br J Psychiatry 203: 297–302.

28. Crump C, Winkleby M A, Sundquist K, Sundquist J (2013). Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 170: 324–333.

29. Cullinan M P, Ford P J, Seymour G J (2009). Periodontal disease and systemic health: current status. Aust Dent J 54: 62–69.

30. Dekker J, Peen J, Koelen J, Smit F, Schoevers R (2008). Psychiatric disorders and urbanization in Germany. BMC Public Health 8: 17.

31. Denis F, Pelletier J-F, Chauvet-Gelinier J-C, Rude N, Trojak B (2018). Oral Health Is a Challenging Problem for Patients with Schizophrenia: A Narrative Review. Iran J Psychiatry Behav Sci 12: e8062.

32. Dickey B, Azeni H, Weiss R, Sederer L (2000). Schizophrenia, substance use disorders and medical co-morbidity. J Ment Health Policy Econ 3: 27–33.

33. DiClemente C C, Prochaska J O (1982). Self-change and therapy change of smoking

154 behavior: A comparison of processes of change in cessation and maintenance.

Addict Behav 7: 133–142.

34. Dipasquale S, Pariante C M, Dazzan P, Aguglia E, McGuire P, Mondelli V (2013). The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res 47: 197–207.

35. Engels G, Francke A L, Meijel B van, Douma J G, Kam H de, Wesselink W, Houtjes W, Scherder E J A (2014). Clinical pain in schizophrenia: a systematic review. J Pain 15: 457–467.

36. Fernández-San-Martín M I, Martín-López L M, Masa-Font R, Olona-Tabueña N, Roman Y, Martin-Royo J, Oller-Canet S, González-Tejón S, San-Emeterio L, Barroso-Garcia A, Viñas-Cabrera L, Flores-Mateo G (2014). The effectiveness of lifestyle interventions to reduce cardiovascular risk in patients with severe mental

disorders: meta-analysis of intervention studies. Community Ment Health J 50: 81–

95.

37. Fine L J, Philogene G S, Gramling R, Coups E J, Sinha S (2004). Prevalence of multiple chronic disease risk factors: 2001 National Health Interview Survey. Am J Prev Med 27: 18–24.

38. Firth J, Rosenbaum S, Stubbs B, Gorczynski P, Yung A R, Vancampfort D (2016).

Motivating factors and barriers towards exercise in severe mental illness: a systematic review and meta-analysis. Psychol Med 46: 2869–2881.

39. Flick U, Kardorff E von, Steinke I (2013). Was ist qualitative Forschung? Einleitung und Überblick. S. 13–29. In: Qualitative Forschung - Ein Handbuch, 10. Aufl., (Flick U, Kardorff E von, Steinke I Hrsg.) Rowohlt Taschenbuch, Reinbek bei Hamburg.

40. Gläser J, Laudel G (2010). Was sind und wofür braucht man Experteninterviews? S.

11–15. In: Experteninterviews und qualitative Inhaltsanalyse, 4. Aufl., VS Verlag für Sozialwissenschaften, Wiesbaden.

41. Gößwald A, Lange M, Kamtsiuris P, Kurth B-M (2012). DEGS: Studie zur Gesundheit Erwachsener in Deutschland. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 55: 775–780.

42. Gühne U, Becker T, Salize H-J, Riedel-Heller S G (2015). Wie viele Menschen in Deutschland sind schwer psychisch krank? Psychiatr Prax 42: 415–423.

43. Gühne U, Weinmann S, Riedel-Heller S, Becker T (2018). Evidenzkapitel:

155 Gesundheitsfördernde Interventionen. S. 315–334. In: S3-Leitlinie Psychosoziale Therapien bei schweren psychischen Erkrankungen. S3-Praxisleitlinien in Psychiatrie und Psychotherapie, 2. Aufl., (DGPPN Hrsg.) Springer, Berlin.

44. Happell B, Davies C, Scott D (2012). Health behaviour interventions to improve physical health in individuals diagnosed with a mental illness: a systematic review.

Int J Ment Health Nurs 21: 236–247.

45. Harangozo J, Reneses B, Brohan E, Sebes J, Csukly G, Lopez-Ibor J J, Sartorius N, Rose D, Thornicroft G (2014). Stigma and discrimination against people with schizophrenia related to medical services. Int J Soc Psychiatry 60: 359–366.

46. Hartung D (2009). Berufsspezifische arbeits- und ernährungsbedingte Herz-Kreislauf-Risiken sowie präventive Maßnahmen. Dissertation zur Erlangung des akademischen Grades doctor rerum naturalium (Dr. rer. nat.), Biologisch-Pharmazeutische Fakultät, Friedrich-Schiller-Universität Jena.

47. Hartz S M, Pato C N, Medeiros H, Cavazos-Rehg P, Sobell J L, Knowles J A, Bierut L J, Pato M T, Consortium G P C (2014). Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry 71: 248–254.

48. Hasselt F M van, Krabbe P F M, Ittersum D G van, Postma M J, Loonen A J M (2013).

Evaluating interventions to improve somatic health in severe mental illness: a systematic review. Acta Psychiatr Scand 128: 251–260.

49. Heald A, Pendlebury J, Anderson S, Narayan V, Guy M, Gibson M, Haddad P, Livingston M (2017). Lifestyle factors and the metabolic syndrome in

Schizophrenia: a cross-sectional study. Ann Gen Psychiatry 16: 12.

50. Hede B (1995). Dental health behavior and self-reported dental health problems among hospitalized psychiatric patients in Denmark. Acta Odontol Scand 53: 35–

40.

51. Hert M de, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei D M, Newcomer J W, Uwakwe R, Asai I, Moeller H-J, Gautam S, Detraux J, Correll C U (2011). Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry 10: 138–151.

52. Hert M de, Correll C U, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Moeller H-J, Ndetei D M, Newcomer J W, Uwakwe R, Leucht S (2011).

156 Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry 10: 52–77.

53. Hopf C (2013). Qualitative Interviews - ein Überblick. S. 349–360. In: Qualitative Forschung - Ein Handbuch, 10. Aufl., (Flick U, Kardorff E von, Steinke I Hrsg.) Rowohlt Taschenbuch, Reinbek bei Hamburg.

54. Hor K, Taylor M (2010). Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol 24: 81–90.

55. Howe K R (1988). Against the quantitative-qualitative incompatibility thesis or dogmas die hard. Educ Res 17: 10–16.

56. Huijbregts P, Feskens E, Räsänen L, Fidanza F, Nissinen A, Menotti A, Kromhout D (1997). Dietary pattern and 20 year mortality in elderly men in Finland, Italy, and the Netherlands: longitudinal cohort study. BMJ 315: 13–17.

57. ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use) (1998). ICH Harmonised Tripartite Guidline - Statistical Principles for Clinical Trials E9. Current Step 4 version.

https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy /E9/Step4/E9_Guideline.pdf (10.06.2019).

58. James M, Painter J, Buckingham B, Stewart M W (2018). A review and update of the Health of the Nation Outcome Scales (HoNOS). BJPsych Bull 42: 63–68.

59. Johnson R B, Onwuegbuzie A J (2004). Mixed methods research: A research paradigm whose time has come. Educ Res 33: 14–26.

60. Johnson R B, Onwuegbuzie A J, Turner L A (2007). Toward a definition of mixed methods research. J Mix Methods Res 1: 112–133.

61. Kelle U (2013). Computergestützte Analyse qualitativer Daten. S. 485–502. In:

Qualitative Forschung - Ein Handbuch, 10. Aufl., (Flick U, Kardoff E von, Steinke I Hrsg.) Rowohlt Taschenbuch, Reinbek bei Hamburg.

62. Khandker S R, Koolwal G B, Samad H A (2010). Propensity Score Matching. S. 53–

68. In: Handbook on Impact Evaluation. Quantitative Methods and Practices, The World Bank, Washington, D.C.

63. Kilbourne A M, Rofey D L, McCarthy J F, Post E P, Welsh D, Blow F C (2007).

Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disord 9: 443–452.

157 64. Kilian R, Becker T, Kruger K, Schmid S, Frasch K (2006). Health behavior in

psychiatric in-patients compared with a German general population sample. Acta Psychiatr Scand 114: 242–248.

65. Kilian R (2000). Lebenslagenspezifische Gesundheitsrisiken, gesundheitsbezogene Orientierungsmuster und primärpräventives Gesundheitsverhalten: eine

pfadanalytische Untersuchung. S.172-177. Mensch und Buch Verlag, Berlin.

66. Kisely S, Baghaie H, Lalloo R, Siskind D, Johnson N W (2015). A systematic review and meta-analysis of the association between poor oral health and severe mental illness. Psychosom Med 77: 83–92.

67. Knight K M, McGowan L, Dickens C, Bundy C (2006). A systematic review of motivational interviewing in physical health care settings. Br J Health Psychol 11:

319–332.

68. Kolip P, Schmidt B (1999). Der Fragebogen zur Erfassung körperlichen Wohlbefindens (FEW 16). Zeitschrift für Gesundheitspsychologie 7: 77–87.

69. Kuss O, Blettner M, Börgermann J (2016). Propensity score: an alternative method of analyzing treatment effects—part 23 of a series on evaluation of scientific publications. Dtsch Arztebl Int 113: 597–603.

70. Lamp N, Müller-Stierlin A S, Schöning V M, Kilian R (2017). Vergleich von Propensity Score Matching und Propensity Score Adjustierung in primärdatenbasierten

Untersuchungen. In: 21. Konferenz der SAS-Anwender in Forschung und Entwicklung, 09.- 10.03.2017, Hochschule Niederrhein Krefeld.

71. Längle G, Steinert T, Weiser P, Schepp W, Jaeger S, Pfiffner C, Frasch K, Eschweiler G W, Messer T, Croissant D, Becker T, Kilian R (2012). Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment. Acta Psychiatr Scand 125: 372–381.

72. Laursen T M (2011). Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res 131: 101–104.

73. Laursen T M, Nordentoft M, Mortensen P B (2014). Excess early mortality in schizophrenia. Annu Rev Clin Psychol 10: 425–448.

74. Lawrence D, Hancock K J, Kisely S (2013). The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia:

retrospective analysis of population based registers. BMJ 346: f2539.

158 75. Lawrence D, Kisely S (2010). Inequalities in healthcare provision for people with

severe mental illness. J Psychopharmacol 24: 61–68.

76. Lawrence P, Fulbrook P, Somerset S, Schulz P (2017). Motivational interviewing to enhance treatment attendance in mental health settings: A systematic review and meta-analysis. J Psychiatr Ment Health Nurs 24: 699–718.

77. Leon J de, Diaz F J (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76: 135–157.

78. Leucht S, Burkard T, Henderson J, Maj M, Sartorius N (2007). Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 116: 317–333.

79. Linardakis M, Smpokos E, Papadaki A, Komninos I D, Tzanakis N, Philalithis A (2013). Prevalence of multiple behavioral risk factors for chronic diseases in adults aged 50 , from eleven European countries—the SHARE study (2004). Prev Med (Baltim) 57: 168–172.

80. Liu N H, Daumit G L, Dua T, Aquila R, Charlson F, Cuijpers P, Druss B, Dudek K, Freeman M, Fujii C, Gaebel W, Hegerl U, Levav I, Laursen T M, Ma H, Maj M, Medina-Mora M E, Nordentoft M, Prabhakaran D, Pratt K, Prince M, Rangaswamy T, Shiers D, Susser E, Thornicroft G, Wahlbeck K, Wassie A F, Whiteford H, Saxena S (2017). Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry 16: 30–40.

81. Löfholm C A, Brännström L, Olsson M, Hansson K (2013). Treatment-as-usual in effectiveness studies: What is it and does it matter? Int J Soc Welf 22: 25–34.

82. Lorenz E, Köpke S, Pfaff H, Blettner M (2018). Cluster-Randomized Studies - part 25 of a series on evaluating scientific publications. Dtsch Arztebl Int 115: 163–168.

83. Lundahl B, Moleni T, Burke B L, Butters R, Tollefson D, Butler C, Rollnick S (2013).

Motivational interviewing in medical care settings: a systematic review and meta-analysis of randomized controlled trials. Patient Educ Couns 93: 157–168.

84. Lundahl B W, Kunz C, Brownell C, Tollefson D, Burke B L (2010). A meta-analysis of motivational interviewing: Twenty-five years of empirical studies. Res Soc Work Pract 20: 137–160.

85. Martins R K, McNeil D W (2009). Review of motivational interviewing in promoting

159 health behaviors. Clin Psychol Rev 29: 283–293.

86. Max Rubner-Institut. Fragebogen Nationale Verzehrsstudie II “WAS ESSE ICH” Die bundesweite Erhebung zur Ernährung von Jugendlichen und Erwachsenen, https://www.mri.bund.de/fileadmin/MRI/Institute/EV/NVS_II_Fragebogen.pdf (06.06.2019).

87. Max Rubner-Institut (2008). Nationale Verzehrsstudie II. Ergebnisbericht, Teil 2. Die bundesweite Befragung zur Ernährung von Jugendlichen und Erwachsenen, Max Rubner-Institut, Karlsruhe.

https://www.bmel.de/SharedDocs/Downloads/Ernaehrung/NVS_ErgebnisberichtT eil2.pdf?__blob=publicationFile (03.06.2019).

88. Max Rubner-Institut (2008). Nationale Verzehrsstudie II. Ergebnisbericht, Teil 1. Die bundesweite Befragung zur Ernährung von Jugendlichen und Erwachsenen, Max Rubner-Institut, Karlsruhe.

https://www.bmel.de/SharedDocs/Downloads/Ernaehrung/NVS_Ergebnisbericht.p df?__blob=publicationFile (03.06.2019).

89. Mayer B, Puschner B (2015). Propensity score adjustment of a treatment effect with missing data in psychiatric health services research. Epidemiol Biostat Public Health 12.

90. Mayring P (2013). Qualitative Inhaltsanalyse. S. 468–475. In: Qualitative Forschung - Ein Handbuch, 10. Aufl., (Flick U, Kardorff E von, Steinke I Hrsg.) Rowohlt

Taschenbuch, Reinbek bei Hamburg.

91. McCloughen A (2003). The association between schizophrenia and cigarette smoking: a review of the literature and implications for mental health nursing practice. Int J Ment Health Nurs 12: 119–129.

92. McGinty E E, Baller J, Azrin S T, Juliano-Bult D, Daumit G L (2016). Interventions to address medical conditions and health-risk behaviors among persons with serious mental illness: a comprehensive review. Schizophr Bull 42: 96–124.

93. Mey L de, Comlekci C, Reuver F de, Waard I van, Gool R van, Scheerman J F M, Meijel B van (2016). Oral Hygiene in Patients With Severe Mental Illness: A Pilot Study on the Collaboration Between Oral Hygienists and Mental Health Nurses.

Perspect Psychiatr Care 52: 194–200.

94. Morris L J, D’Este C, Sargent-Cox K, Anstey K J (2016). Concurrent lifestyle risk

160 factors: Clusters and determinants in an Australian sample. Prev Med (Baltim) 84:

1–5.

95. Murakami H, Tamasawa N, Yamashita M, Takayasu S, Nigawara T, Matsui J, Suda T (2010). Altered pain perception in schizophrenia (Case Report). Lancet 375: 864.

96. Nielsen R E, Uggerby A S, Jensen S O W, McGrath J J (2013). Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades -- A Danish nationwide study from 1980 to 2010. Schizophr Res 146: 22–27.

97. Nishanth K N, Chadda R K, Sood M, Biswas A, Lakshmy R (2017). Physical comorbidity in schizophrenia & its correlates. Indian J Med Res 146: 281–284.

98. Normand S T, Landrum M B, Guadagnoli E, Ayanian J Z, Ryan T J, Cleary P D, McNeil B J (2001). Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. J Clin Epidemiol 54: 387–398.

99. Olfson M, Gerhard T, Huang C, Crystal S, Stroup T S (2015). Premature Mortality Among Adults With Schizophrenia in the United States. JAMA Psychiatry 72: 1172–

1181.

100. Onwuegbuzie A J, Leech N L (2004). Enhancing the interpretation of significant findings: The role of mixed methods research. Qual Rep 9: 770–792.

101. Park A-L, McDaid D, Weiser P, Gottberg C von, Becker T, Kilian R (2013). Examining the cost effectiveness of interventions to promote the physical health of people with mental health problems: a systematic review. BMC Public Health 13: 787.

102. Patchan K M, Richardson C, Vyas G, Kelly D L (2015). The risk of suicide after clozapine discontinuation: Cause for concern. Ann Clin Psychiatry 27: 253–256.

103. Prochaska J O, DiClemente C C (1983). Stages and processes of self-change of smoking: Toward an integrative model of change. J Consult Clin Psychol 51: 390–

395.

104. Prochaska J O, DiClemente C C (1982). Transtheoretical therapy: Toward a more integrative model of change. Psychotherapy: Theory, Research & Practice 19: 276–

288.

105. Prochaska J J, Spring B, Nigg C R (2008). Multiple health behavior change research:

an introduction and overview. Prev Med (Baltim) 46: 181–188.

106. Rebscher H. Allgemeine Ortskrankenkasse (AOK).

161 https://www.versicherungsmagazin.de/lexikon/allgemeine-ortskrankenkasse-aok-1944467.html (05.08.2019).

107. Regier D A, Farmer M E, Rae D S, Locke B Z, Keith S J, Judd L L, Goodwin F K (1990).

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264: 2511–2518.

108. Roberts S H, Bailey J E (2013). An ethnographic study of the incentives and barriers to lifestyle interventions for people with severe mental illness. J Adv Nurs 69:

2514–2524.

109. Roick C, Fritz-Wieacker A, Matschinger H, Heider D, Schindler J, Riedel-Heller S, Angermeyer M C (2007). Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 42: 268–276.

110. Roick C, Kilian R, Matschinger H, Bernert S, Mory C, Angermeyer M C (2001). Die deutsche Version des Client Sociodemographic and Service Receipt Inventory.

Psychiatr Prax 28: 84–90.

111. Rosenbaum P R, Rubin D B (1983). The central role of the propensity score in observational studies for causal effects. Biometrika 70: 41–55.

112. Rotter J B (1966). Generalized expectancies for internal versus external control of reinforcement. Psychol Monogr 80: 1–28.

113. Rubak S, Sandbaek A, Lauritzen T, Christensen B (2005). Motivational interviewing:

a systematic review and meta-analysis. Br J Gen Pract 55: 305–312.

114. Ruggeri M, Leese M, Thornicroft G, Bisoffi G, Tansella M (2000). Definition and prevalence of severe and persistent mental illness. Br J Psychiatry 177: 149–155.

115. Saffer H, Dave D (2005). Mental illness and the demand for alcohol, cocaine, and cigarettes. Econ Inq 43: 229–246.

116. Saha S, Chant D, McGrath J (2007). A systematic review of mortality in

schizophrenia: is the differential mortality gap worsening over time?. Arch Gen Psychiatry 64: 1123–1131.

117. Sakpal T V (2010). Sample Size Estimation in Clinical Trial. Perspect Clin Res 1: 67–

69.

118. Scheidt-Nave C, Kamtsiuris P, Göswald A, Hölling H, Lange M, Busch M A, Dahm S, Dölle R, Ellert U, Fuchs J, Hapke U, Heidemann C, Knopf H, Laussmann D, Mensink G B M, Neuhauser H, Richter A, Sass A-C, Rosario A S, Stolzenberg H, Thamm M,

162 Kurth B-M (2012). German health interview and examination survey for adults (DEGS) - design, objectives and implementation of the first data collection wave.

BMC Public Health 12: 730.

119. Schinnar A P, Rothbard A B, Kanter R, Jung Y S (1990). An empirical literature review of definitions of severe and persistent mental illness. Am J Psychiatry 147:

1602–1608.

120. Schneider R, Heseker H (2006). Erfassung von Ernährungsgewohnheiten. S. 498–

505. In: Ernährungsmedizin: Prävention und Therapie, 3. Aufl., (Schauder P, Ollenschläger G Hrsg.) Urban & Fischer, Elsevier, München.

121. Schnell T, Neisius K, Daumann J, Gouzoulis-Mayfrank E (2010). Prävalenz der Komorbidität Psychose und Sucht. Nervenarzt 81: 323–328.

122. Schutz Y (2004). Bestimmung des Ernährungszustandes. S. 19–26. In:

Ernährungsmedizin: Nach dem Curriculum Ernährungsmedizin der

Bundesärztekammer, 3. Aufl., (Biesalski H K, Fürst P, Kasper H, Kluthe R, Pölert W, Puchstein C, Stähelin H B Hrsg.) Thieme, Stuttgart, New York.

123. Schwarz B, Wienert J, Bethge M (2016). RCTs vorgeschaltete

Implementierungsstudien: Wie sie helfen können, den failure of implementation zu minimieren. S. 37–39. In: 25. Rehabilitationswissenschaftliches Kolloquium.

Deutscher Kongress für Rehabilitationsforschung. Gesundheitssystem im Wandel – Perspektiven der Rehabilitation vom 29. Februar bis 2. März 2016 in Aachen, (Deutsche Rentenversicherung Bund Hrsg.).

124. Scott K M, Lim C, Al-Hamzawi A, Alonso J, Bruffaerts R, Caldas-de-Almeida J M, Florescu S, Girolamo G de, Hu C, Jonge P de, Kawakami N, Medina-Mora M E, Moskalewicz J, Navarro-Mateu F, O’Neill S, Piazza M, Posada-Villa J, Torres Y, Kessler R C (2016). Association of Mental Disorders With Subsequent Chronic Physical Conditions: World Mental Health Surveys From 17 Countries. JAMA Psychiatry 73: 150–158.

125. Shiner B, Whitley R, Citters A D Van, Pratt S I, Bartels S J (2008). Learning what matters for patients: qualitative evaluation of a health promotion program for those with serious mental illness. Health Promot Int 23: 275–282.

126. Singh M K, Giles L L, Nasrallah H A (2006). Pain insensitivity in schizophrenia: trait or state marker?. J Psychiatr Pract 12: 90–102.

163 127. Smith D J, Langan J, McLean G, Guthrie B, Mercer S W (2013). Schizophrenia is

associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study. BMJ Open 3: e002808.

128. Soundy A, Freeman P, Stubbs B, Probst M, Coffee P, Vancampfort D (2014). The transcending benefits of physical activity for individuals with schizophrenia: A systematic review and meta-ethnography. Psychiatry Res 220: 11–19.

129. Stanley S, Laugharne J (2014). The Impact of Lifestyle Factors on the Physical Health of People with a Mental Illness: a Brief Review. Int J Behav Med 21: 275–

281.

130. Steinke I (2013). Gütekriterien qualitativer Forschung. S. 319–331. In: Qualitative Forschung - Ein Handbuch, 10. Aufl., (Flick U, Kardorff E von, Steinke I Hrsg.) Rowohlt Taschenbuch, Reinbek bei Hamburg.

131. Stubbs B, Vancampfort D, Bobes J, Hert M de, Mitchell A J (2015). How can we promote smoking cessation in people with schizophrenia in practice? A clinical overview. Acta Psychiatr Scand 132: 122–130.

132. Stubbs B, Firth J, Berry A, Schuch F B, Rosenbaum S, Gaughran F, Veronesse N, Williams J, Craig T, Yung A R, Vancampfort D (2016). How much physical activity do people with schizophrenia engage in? A systematic review, comparative meta-analysis and meta-regression. Schizophr Res 176: 431–440.

133. Stubbs B, Mitchell A J, Hert M de, Correll C U, Soundy A, Stroobants M,

Vancampfort D (2014). The prevalence and moderators of clinical pain in people with schizophrenia: a systematic review and large scale meta-analysis. Schizophr Res 160: 1–8.

134. Sweet S N, Fortier M S (2010). Improving physical activity and dietary behaviours with single or multiple health behaviour interventions? A synthesis of meta-analyses and reviews. Int J Environ Res Public Health 7: 1720–1743.

135. Sylvia L G, Bernstein E E, Hubbard J L, Keating L, Anderson E J (2014). Practical guide to measuring physical activity. J Acad Nutr Diet 114: 199–208.

136. Taipale H, Mittendorfer-Rutz E, Alexanderson K, Majak M, Mehtala J, Hoti F, Jedenius E, Enkusson D, Leval A, Sermon J, Tanskanen A, Tiihonen J (2017).

Antipsychotics and mortality in a nationwide cohort of 29,823 patients with

164 schizophrenia. Schizophr Res 197: 274–280.

137. Techniker Krankenkasse (2017). Krankenversicherung wird Pflicht - die Geburtsstunde der TK.

https://www.tk.de/techniker/unternehmensseiten/unternehmen/ueber-die-tk/krankenversicherung-wird-pflicht-die-geburtsstunde-der-tk-2012362 (05.08.2019).

138. Thornicroft G (2011). Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry 199: 441–442.

139. Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J (2009). 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 374: 620–627.

140. Toftegaard K L, Gustafsson L N, Uwakwe R, Andersen U A, Becker T, Bickel G G,

140. Toftegaard K L, Gustafsson L N, Uwakwe R, Andersen U A, Becker T, Bickel G G,